Evolent Health, Inc. 4
4 · Evolent Health, Inc. · Filed May 17, 2017
Insider Transaction Report
Form 4
Peterson Thomas III
Chief Operating Officer
Transactions
- Sale
Class A Common Stock
2017-05-15$25.00/sh−20,777$519,425→ 341,092 total - Sale
Class A Common Stock
2017-05-15$24.99/sh−20,777$519,217→ 320,315 total - Sale
Class A Common Stock
2017-05-15$24.99/sh−20,777$519,217→ 299,538 total - Sale
Class A Common Stock
2017-05-15$24.99/sh−20,777$519,217→ 278,761 total
Footnotes (5)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2017.
- [F2]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.90-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.85-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.85-$25.35, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.